ICH Plans New Guideline On Pharmacoepidemiological Studies Using RWD
Saudi FDA Is ICH’s Latest Regulatory Member; Azerbaijan & UK Join As Observers
Executive Summary
At its latest meeting in June, the International Council for Harmonisation agreed on new topics that could benefit from harmonized advice and took note of progress made on drafting and finalizing quality, safety and multidisciplinary guidelines.
You may also be interested in...
UK Regulator Eyes Expedited Process For Securing Full ICH Membership
The UK is on a mission to re-join the International Council for Harmonisation as a fully active member with voting rights.
Efforts Build For Global Approach To Patient-Focused Drug Development
The International Council for Harmonisation wants to ensure that methods used to collect and integrate patient views into drug development and regulatory decision-making follow agreed standards.
ICH Evaluates Guideline Uptake By New And Old Members
The study will be undertaken by an independent third party and its results will help facilitate a transparent dialogue on the long-term goal of ensuring that all the ICH regulators implement all the ICH guidelines.